iShares Biotechnology ETFIBB

iSharesSectorsTechnology#33 of 264 by YTD

$215.47

+0.8% last session

+27.8% YTD

Data as of 11/3/20264:00 PM ET · End-of-day

Dividend-adjusted total return · Nov 21, 2006 – Nov 3, 2026IBB

Returns	1D	1M	3M	YTD	1Y	3Y	5Y	MAX
Total return	+0.8%	+3.6%	+12.3%	+27.8%	+35.5%	+93.1%	+36.3%	+728.7%
Peer average	+1.1%	−9.6%	−6.2%	+8.6%	+5.3%	+90.4%	+32.3%	—
S&P 500 · VOO	+0.3%	−2.6%	−1.7%	+11.5%	+11.9%	+90.9%	+77.5%	—

Key Statistics

Open all fund facts →

AUM: $11.2B
Expense ratio: 0.44%
Distribution yield: 0.2%
NAV: $215.42
Volume: 1.7M
Avg. volume 30D: 1.8M
High today: $218.12
Low today: $214.52
Previous close: $213.79
52-week high: $222.29
52-week low: $154.62
Our risk indicator: 4/5

IBB in One Breath

IBB Among Technology ETFs

YTD

#1GNOMGlobal X+49.8%$109M

#2PSCTInvesco+38.5%$475M

#3FBTFirst Trust+33.7%$3.1B

#4PTFInvesco+27.9%$535M

#5IBBQInvesco+27.8%$120M

#6IBBiShares+27.8%$11.2B

#7SPTESP Funds+27.7%$243M

#8IXNiShares+26.9%$8.8B

#9SNSRGlobal X+26.3%$196M

End-of-day Nov 4, 2026 · 54 Technology ETFs by YTD

$10,000 in IBB

$10,000 in IBB became

$13,634

In the S&P 500 (VOO)

$17,749

Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO

IBB’s Top Holdings

Today

GILDGilead Sciences8.9%AMGN8.3%VRTX7.9%REGN6.2%MRNA5.5%NTRA3.8%ARGX3.4%BIIB2.5%RVMD2.5%ILMN2.4%GMAB2.1%ONC2.1%UTHR1.7%INSM1.6%INCY1.6%ALNY1.5%ROIV1.3%CRL1.2%EXEL1.1%ASNDHALONBIX221 more

GILDGilead Sciences8.9%AMGN8.3%VRTX7.9%REGN6.2%MRNA5.5%NTRA3.8%ARGX3.4%BIIB2.5%RVMD2.5%ILMN2.4%GMAB2.1%ONC231 more

BiotechnologyDrug Manufacturers - GeneralMedical - Diagnostics

iShares IBB · 243 holdings · tile size = share of the fund · as of Nov 3, 2026

What IBB Holds

Today

Biotechnology63.1%

VRTX 7.9 · REGN 6.2 · MRNA 5.5 · ARGX 3.4 · RVMD 2.5 · GMAB 2.1 · ONC 2.1

Drug Manufacturers - General19.9%

GILD 8.9 · AMGN 8.3 · BIIB 2.5 · GRFS

Medical - Diagnostics & Research9.3%

NTRA 3.8 · ILMN 2.4 · CRL 1.2 · MEDP · GRAL · CDNA · VCYT

Medical - Instruments & Supplies0.7%

RGEN

Medical - Healthcare Information Services0.5%

TEM

Drug Manufacturers - Specialty & Generic0.5%

ALKS

Medical - Devices0.4%

BRKR

iShares IBB · share of the fund by industry · as of Nov 3, 2026

Gilead’s Share of IBB

Today

8.9%

$89 of every $1,000 in IBB is Gilead

Gilead held by IBB

$1.0B

Most Gilead per dollar

BBH14.5%

IBBQ9.2%

IBB8.9%

PJP6.1%

iShares IBB · each square = $10 of $1,000 · as of Nov 3, 2026

IBB’s Share of Technology ETFs

Today

3.1%

of the $366B in 58 Technology ETFs

IBB$11.2B3.1%

VGT$155B42.3%

XLK$115B31.5%

55 others$84.8B23.2%

Technology ETF AUM · Nov 4, 2026

IBB Fee per $100 vs Peers

Today

$0.44a year
per $100

$44 a year on $10,000

XLK$0.08

FTEC$0.08

VGT$0.09

IYW$0.37

IXN$0.37

IBB$0.44

Expense ratio · Technology peers · Nov 4, 2026

Inside IBB

243 holdings · as of Nov 3, 2026

IBB

iShares Biotechnology ETF

Today

Biotechnology63.1%VRTX7.9%REGN6.2%MRNA5.5%ARGX3.4%RVMD2.5%GMAB2.1%ONC2.1%UTHR1.7%INSMINCYALNYROIVEXEL70 more holdings23.5% of the fundDrug Manufacturers - General19.9%GILD8.9%AMGN8.3%BIIBMedical - Diagnostics9.3%NTRA3.8%ILMNCRLMEDPCDNAVCYTRGENTEMALKSOther5.5%

Biotechnology63.1%VRTX7.9%REGN6.2%MRNA5.5%ARGXRVMDGMAB78 more holdings35.5% of the fundDrug Manufacturers - General19.9%GILD8.9%AMGN8.3%BIIBMedical - Diagnostics9.3%NTRAILMNCRLRGENOther5.5%

#	Ticker	Company	Weight ▼
1	GILD	Gilead Sciences	8.94%
2	AMGN	Amgen	8.31%
3	VRTX	Vertex Pharmaceuticals	7.87%
4	REGN	Regeneron Pharmaceuticals	6.24%
5	MRNA	Moderna	5.49%
6	NTRA	Natera	3.78%
7	ARGX	Argenx SE	3.36%
8	BIIB	Biogen	2.52%
9	RVMD	Revolution Medicines	2.50%
10	ILMN	Illumina	2.41%

BiotechnologyDrug Manufacturers - GeneralMedical - DiagnosticsMedical - InstrumentsMedical - Healthcare Information ServicesDrug Manufacturers - SpecialtyMedical - DevicesOther

iShares IBB · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 66.8%

How It Compares

IBB

iShares Biotechnology ETF’s Peers

YTD


VGT	VanguardRead Desk	0.09%	+22.8%	+16.8%	$154.5B
XLK	SPDRRead Desk	0.08%	+23.0%	+18.0%	$115.0B
IYW	iSharesRead Desk	0.37%	+20.0%	+15.2%	$23.5B
FTEC	FidelityRead Desk	0.08%	+22.8%	+16.9%	$22.1B
IBB	iSharesThis fundRead Desk	0.44%	+27.8%	+35.5%	$11.2B
IXN	iSharesRead Desk	0.37%	+26.9%	+21.7%	$8.8B

Technology peers · YTD and past-year returns · as of Nov 4, 2026 · sorted by AUM

Head to Head

Put IBB head to head with VGT →

VGT vs IBB

YTD

VGTVanguard · TechnologyIBBiShares · Technology

Year to date

+22.8%

+27.8%

IBB wins+5.0 pts

Past year

+16.8%

+35.5%

IBB wins+18.7 pts

Fee

0.09%

0.44%

VGT winslower fee

Yield

0.4%

0.2%

VGT wins+0.3 pts

AUM

$155B

$11.2B

VGT13.7× more

2–2level

Vanguard VGT and iShares IBB · year-to-date · as of Nov 4, 2026 · AUM not scored

IBB vs VOO

YTD

IBB · iShares Biotechnology

+27.8%

VOO · S&P 500

+11.5%

Gap

16.2 pts

iShares IBB and Vanguard VOO · YTD total return · as of Nov 4, 2026

IBB vs Its Peer Average

YTD

IBBAvsBPeer average

1D+0.8%+1.1%

1M+3.6%−9.6%

3M+12.3%−6.2%

YTD+27.8%+8.6%

1Y+35.5%+5.3%

3Y+93.1%+90.4%

5Y+36.3%+32.3%

6–1IBB wins

57 Technology peers · each row scaled to its leader

The Details

IBB

Risk

4/5our risk indicator

CalmerBumpier

Volatility · 1Y22.73%

Deepest drop · 1Y−9.6%

Lowest point · 5Y−33.5%

52-week range

$215.47

$154.62−3.1% from the high$222.29

iShares IBB · past-year price moves · as of Nov 4, 2026

IBB

Fund Facts

Today

2001launched Feb 5

Tracks[…]

Exchange · CUSIPNASDAQ · 464287556

StructureETF

Leverage1x

Cost on $10,000$44 a year

Go deeper

Prospectus & documents Trading & liquidity Fees & costs Distributions

iShares IBB · fund facts · as of Nov 4, 2026

IBB

Payouts by Year

13Y

$0.0112per share, Sep 2026

Distribution yield0.2%

PaidEvery quarter

Latest ex-date · paidSep 15 · Sep 18, 2026

12 payouts added up$1.22 a share

iShares IBB · distributions by ex-date · 2014–2026

All Fund FactsDocuments · trading · fees · every payout

Prospectus & Documents

SEC reported portfolio · 2026-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-09-30 ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗

Trading & Liquidity

Net asset value$215.42

Premium / discount[…]

Median spread · 30D[…]

Volume today1.7M

Average volume · 30D1.8M

Shares outstanding[…]

Options[…]

Fees & Costs

Net expense ratio0.44%

Gross expense ratio[…]

Management fee[…]

Cost on $10,000 a year$44.00

Our risk indicator4/5

Estimated yearly cost excludes trading costs and assumes constant assets.

Distributions

Ex-date	Paid	Per share
Sep 15, 2026	Sep 18, 2026	$0.0112
Jun 15, 2026	Jun 18, 2026	$0.0238
Mar 17, 2026	Mar 20, 2026	$0.12
Dec 16, 2025	Dec 19, 2025	$0.18
Sep 16, 2025	Sep 19, 2025	$0.0828
Mar 18, 2025	Mar 21, 2025	$0.12
Dec 17, 2024	Dec 20, 2024	$0.0624
Sep 25, 2024	Sep 30, 2024	$0.20
Mar 21, 2024	Mar 27, 2024	$0.13
Dec 20, 2023	Dec 27, 2023	$0.12
Sep 26, 2023	Oct 2, 2023	$0.15
Jun 7, 2023	Jun 13, 2023	$0.0062

Issuer contentFrom iSharesHear the strategy from the people behind IBB.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →